Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Neurol ; 62(2): 121-7, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17683097

ABSTRACT

OBJECTIVE: To define the clinical and laboratory findings in a novel autosomal recessive white matter disorder called hypomyelination and congenital cataract, recently found to be caused by a deficiency of a membrane protein, hyccin, encoded by the DRCTNNB1A gene located on chromosome 7p21.3-p15.3. METHODS: We performed neurological examination, neurophysiological, neuroimaging, and neuropathological studies on sural nerve biopsy in 10 hypomyelination and congenital cataract patients from 5 unrelated families. RESULTS: The clinical picture was characterized by bilateral congenital cataract, developmental delay, and slowly progressive neurological impairment with spasticity, cerebellar ataxia, and mild-to-moderate mental retardation. Neurophysiological studies showed a slightly to markedly slowed motor nerve conduction velocity in 9 of 10 patients, and multimodal evoked potentials indicated increased central conduction times. Neuroimaging studies demonstrated a diffuse supratentorial hypomyelination, with in some patients, additional areas of more prominent signal change in the frontal region. Sural nerve biopsy showed a slight-to-severe reduction in myelinated fiber density, with several axons surrounded by a thin myelin sheath or devoid of myelin. INTERPRETATION: Hypomyelination and congenital cataract is a novel autosomal recessive white matter disorder characterized by the unique association of congenital cataract and hypomyelination of the central and peripheral nervous system.


Subject(s)
Cataract/congenital , Cataract/physiopathology , Demyelinating Diseases/physiopathology , Hereditary Central Nervous System Demyelinating Diseases/physiopathology , Magnetic Resonance Imaging , Peripheral Nervous System Diseases/physiopathology , Biopsy , Cataract/complications , Cataract/genetics , Cerebellar Ataxia/etiology , Demyelinating Diseases/complications , Demyelinating Diseases/genetics , Female , Genes, Recessive , Hereditary Central Nervous System Demyelinating Diseases/complications , Hereditary Central Nervous System Demyelinating Diseases/diagnosis , Hereditary Central Nervous System Demyelinating Diseases/genetics , Humans , Intellectual Disability/etiology , Intracellular Signaling Peptides and Proteins/deficiency , Male , Membrane Proteins/deficiency , Muscle Spasticity/etiology , Nervous System/pathology , Nervous System/physiopathology , Neural Conduction , Peripheral Nervous System Diseases/complications , Peripheral Nervous System Diseases/genetics , Phenotype , Retrospective Studies , Single-Blind Method , Sural Nerve/pathology
2.
Muscle Nerve ; 28(4): 508-11, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14506725

ABSTRACT

We report a novel nonsense mitochondrial cytochrome b mutation (G15170A) in a 40-year-old woman with progressive exercise intolerance and lactic acidosis. Muscle biopsy showed several cytochrome c oxidase-positive ragged-red fibers, and reduced activities of respiratory chain complexes I and III. This mutation, resulting in the loss of 228 amino acids of the protein, was very abundant in the patient's muscle, but undetectable in lymphocytes and fibroblasts. Clinical and laboratory data indicate that this defect is the primary cause of the disease, thus adding a new mutation in the cytochrome b gene among the growing number of patients with exercise intolerance and lactic acidosis.


Subject(s)
Codon, Nonsense , Cytochrome b Group/genetics , DNA, Mitochondrial/genetics , DNA, Mitochondrial/metabolism , Exercise/physiology , Muscle, Skeletal/metabolism , Acidosis, Lactic/genetics , Adult , Base Sequence/genetics , Electron Transport Complex I , Electron Transport Complex III/metabolism , Electron Transport Complex IV/metabolism , Female , Humans , Muscle Cramp/genetics , Muscle Fibers, Skeletal/enzymology , Muscle Fibers, Skeletal/pathology , Muscle, Skeletal/pathology , NADH, NADPH Oxidoreductases/metabolism
3.
J Child Neurol ; 18(4): 300-3, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12760436

ABSTRACT

We report a novel T14687C mutation in the mitochondrial transfer ribonucleic acid glutamic acid gene in a 16-year-old boy with myopathy and lactic acidosis, retinopathy, and progressive respiratory failure leading to death. A muscle biopsy showed cytochrome c oxidase-negative ragged-red fibers, and biochemical analysis of the respiratory chain enzymes in muscle homogenate revealed complex I and complex IV deficiencies. The mutation, which affects the trinucleotide (TpsiC) loop, was nearly homoplasmic in the muscle DNA of the proband, but it was absent in his blood and in the blood from the asymptomatic mother, suggesting that it may have been a spontaneous somatic mutation in muscle.


Subject(s)
Mitochondria/genetics , Mitochondrial Myopathies/genetics , Mutation/genetics , RNA, Transfer, Amino Acyl/genetics , Respiratory Insufficiency/genetics , Adolescent , Humans , Male , Mitochondria/pathology , Mitochondrial Myopathies/pathology , Respiratory Insufficiency/pathology
4.
FASEB J ; 16(9): 1120-2, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12039847

ABSTRACT

Duchenne Muscular Dystrophy (DMD) is a progressive lethal muscle disease that affects young boys. Dystrophin, absent in DMD and reduced in the milder form Becker Muscular Dystrophy (BMD), binds to several membrane-associated proteins known as dystrophin-associated proteins (DAPs). Once this critical structural link is disrupted, muscle fibers become more vulnerable to mechanical and osmotic stress. Recently, we have reported that the expression of aquaporin-4 (AQP4), a water-selective channel expressed in the sarcolemma of fast-twitch fibers and astrocyte end-feet, is drastically reduced in the muscle and brain of the mdx mouse, the animal model of DMD. In the present study, we analyzed the expression of AQP4 in several DMD/BMD patients of different ages with different mutations in the dystrophin gene. Immunofluorescence results indicate that, compared with healthy control children, AQP4 is reduced severely in all the DMD muscular biopsies analyzed and in 50% of the analyzed BMD. Western blot analysis revealed that the deficiency in sarcolemma AQP4 staining is due to a reduction in total AQP4 muscle protein content rather than to changes in immunoreactivity. Double-immunostaining experiments indicate that AQP4 reduction is independent of changes in the fiber myosin heavy chain composition. AQP4 and a-syntrophin analysis of BMD muscular biopsies revealed that the expression and stability of AQP4 in the sarcolemma does not always decrease when a-syntrophin is strongly reduced. Finally, limb-girdle muscular dystrophy biopsies and facioscapulohumeral muscular dystrophy revealed that AQP4 expression was not altered in these forms of muscular dystrophy. These experiments provide the first evidence of AQP4 reduction in a human pathology and show that this deficiency is an important feature of DMD/BMD.


Subject(s)
Aquaporins/metabolism , Muscular Dystrophies/metabolism , Aquaporin 4 , Aquaporins/immunology , Calcium-Binding Proteins , Fluorescent Antibody Technique , Humans , Membrane Proteins/metabolism , Models, Biological , Muscle Fibers, Fast-Twitch/chemistry , Muscle Proteins/metabolism , Muscular Dystrophy, Duchenne/metabolism , Muscular Dystrophy, Facioscapulohumeral/metabolism
5.
J Child Neurol ; 17(3): 233-6, 2002 Mar.
Article in English | MEDLINE | ID: mdl-12026244

ABSTRACT

We report a 16-month-old boy with psychomotor regression, muscle hypotonia, peripheral neuropathy, and lactic acidosis. Brain magnetic resonance imaging showed a bilateral abnormal signal in the substantia nigra and in the subthalamic nucleus, suggestive of Leigh disease. Histochemical analysis of skeletal muscle showed decreased cytochrome-c oxidase activity. Biochemical analysis of respiratory chain enzymes in muscle homogenate and in cultured fibroblasts showed isolated cytochrome-c oxidase deficiency. Western blot analysis in fibroblasts showed the absence of Surf1 protein. Genetic analysis of the SURF1 gene revealed that the patient was compound heterozygous for a previously reported mutation at the splice-junction site of intron 3 (240 + 1G > T), and for a novel 4-bp deletion in exon 6 (531_534delAAAT). Our data further enlarge the spectrum of mutations in SURF1 gene in patients with Leigh disease and cytochrome-c oxidase deficiency, contributing to better characterization of the clinical and neuroradiologic features of this group of patients for genotype-phenotype correlations.


Subject(s)
Cytochrome-c Oxidase Deficiency/complications , Leigh Disease/complications , Leigh Disease/genetics , Membrane Proteins/genetics , Peripheral Nervous System Diseases/complications , Point Mutation/genetics , Biopsy , Blotting, Southern , Brain/pathology , Cytochrome-c Oxidase Deficiency/enzymology , DNA Mutational Analysis , Humans , Infant , Magnetic Resonance Imaging , Male , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology
6.
Am J Pathol ; 160(1): 265-70, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11786420

ABSTRACT

Caveolin-3, a muscle specific caveolin-related protein, is the principal structural protein of caveolar membranes. We have recently identified an autosomal dominant form of limb girdle muscular dystrophy (LGMD-1C) that is due to caveolin-3 deficiency and caveolin-3 gene mutations. Here, we studied by electron microscopy, including freeze-fracture and lanthanum staining, the distribution of caveolae and the organization of the T-tubule system in caveolin-3 deficient human muscle fibers. We found a severe impairment of caveolae formation at the muscle cell surface, demonstrating that caveolin-3 is essential for the formation and organization of caveolae in muscle fibers. In addition, we also detected a striking disorganization of the T-system openings at the sub-sarcolemmal level in LGMD-1C muscle fibers. These observations provide new perspectives in our understanding of the role of caveolin-3 in muscle and of the pathogenesis of muscle weakness in caveolin-3 deficient muscle.


Subject(s)
Caveolae/physiology , Caveolins/deficiency , Muscle, Skeletal/ultrastructure , Muscular Dystrophies/metabolism , Muscular Dystrophies/pathology , Adolescent , Caveolae/ultrastructure , Caveolin 3 , Child , Freeze Fracturing , Humans , Immunohistochemistry , Lanthanum , Microscopy, Electron , Middle Aged , Staining and Labeling
SELECTION OF CITATIONS
SEARCH DETAIL
...